The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $29.25

Today's change0.00 0.00%
Updated December 5 10:40 AM EST. Delayed by at least 15 minutes.
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $29.25

Today's change0.00 0.00%
Updated December 5 10:40 AM EST. Delayed by at least 15 minutes.

Omega Healthcare Investors Inc unchanged

Omega Healthcare Investors Inc is unchanged today sitting at (U.S.)$29.25. Over the last five days, shares have gained 0.48%, but are down 16.38% for the last year to date. Shares have underperformed the S&P 500 by 18.53% during the last year.

Key company metrics

  • Open(U.S.) $29.22
  • Previous close(U.S.) $29.25
  • High(U.S.) $29.40
  • Low(U.S.) $29.11
  • Bid / Ask(U.S.) $29.25 / (U.S.) $29.26
  • YTD % change-16.38%
  • Volume278,096
  • Average volume (10-day)2,360,453
  • Average volume (1-month)3,052,933
  • Average volume (3-month)2,278,799
  • 52-week range(U.S.) $26.96 to (U.S.) $38.09
  • Beta0.55
  • Trailing P/E19.31×
  • P/E 1 year forward16.97×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.44
  • Dividend yield8.34%
  • Trailing EPS(U.S.) $1.51
Updated December 5 10:40 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+36.16%

Based on its net profit margin of 36.16%, Omega Healthcare Investors Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.30%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue225229213211
Total other revenue--------
Total revenue225229213211
Gross profit--------
Total cost of revenue--------
Total operating expense1008711686
Selling / general / administrative12111620
Research & development--------
Depreciation / amortization68666261
Interest expense (income), net operating--------
Unusual expense (income)2010385
Other operating expenses, total--------
Operating income12414297125
Interest income (expense), net non-operating-45-42-39-41
Gain (loss) on sale of assets51320
Other--------
Income before tax821145864
Income after tax821135864
Income tax, total0000
Net income791085661
Total adjustments to net income--------
Net income before extra. items791085661
Minority interest-4-5-3-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items791085661
Inc. avail. to common incl. extra. items791085661
Diluted net income791085661
Dilution adjustment--------
Diluted weighted average shares204199198198
Diluted EPS excluding extraordinary itemsvalue per share0.380.540.280.31
Dividends per sharevalue per share0.600.580.570.56
Diluted normalized EPSvalue per share0.460.530.460.33